Us Bancorp \De\ Lyra Therapeutics, Inc. Transaction History

Us Bancorp \De\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	BUY	$10.38 - $15.61 $5,190 - $7,805	500 New	500 $6,000
Q4 2020 Feb 04, 2021	SELL	$9.28 - $13.88 $2,784 - $4,164	-300 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$10.91 - $18.56 $3,273 - $5,568	300 New	300 $3,000

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $124M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.